AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Dec 12, 2012
31971_dirs_2012-12-12_7fb8c34f-792e-4a8e-974c-59b6fd115179.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-12-11
Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-11 | Common Stock | M | 10000 | $25.03 | Acquired | 17138 | Direct |
| 2012-12-11 | Common Stock | S | 10000 | $28.0301 | Disposed | 7138 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-11 | Options To Purchase Common Stock | $25.03 | M | 10000 | Disposed | 2014-05-18 | Common Stock (10000) | Direct |
Footnotes
F1: Full information regarding the number of shares sold at each seperate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: 5 year vesting schedule, 20% vest each year starting 5/18/2005.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7